Statement of Lymphoma Research Foundation on Access to Treatment
Policymakers in Washington, DC, and state capitols are considering measures to address the cost of health care, including prescription drugs, and to address insurance adequacy issues. As debate on these initiatives intensifies, we urge that policymakers consider the needs of people with lymphoma and lymphoma survivors.
